BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28668166)

  • 1. PET/MR Imaging in Gynecologic Oncology.
    Ohliger MA; Hope TA; Chapman JS; Chen LM; Behr SC; Poder L
    Magn Reson Imaging Clin N Am; 2017 Aug; 25(3):667-684. PubMed ID: 28668166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of PET/MR Imaging in Urogynecologic and Genitourinary Cancers.
    Oldan JD; Shah SN; Rose TL
    Magn Reson Imaging Clin N Am; 2017 May; 25(2):335-350. PubMed ID: 28390533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of PET/MR Imaging in Gynecologic Cancers.
    Ponisio MR; Fowler KJ; Dehdashti F
    PET Clin; 2016 Oct; 11(4):425-40. PubMed ID: 27593247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/MRI Evaluation of Gynecologic Malignancies and Prostate Cancer.
    Bagade S; Fowler KJ; Schwarz JK; Grigsby PW; Dehdashti F
    Semin Nucl Med; 2015 Jul; 45(4):293-303. PubMed ID: 26050657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/MR Imaging of the Female Pelvis.
    Umutlu L; Antoch G; Herrmann K; Grueneisen J
    Semin Nucl Med; 2019 Nov; 49(6):512-520. PubMed ID: 31630735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/MR imaging in gynecologic cancer: tips for differentiating normal gynecologic anatomy and benign pathology versus cancer.
    Sadowski EA; Pirasteh A; McMillan AB; Fowler KJ; Kusmirek JE
    Abdom Radiol (NY); 2022 Sep; 47(9):3189-3204. PubMed ID: 34687323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/MRI in Gynecologic Malignancy.
    Larson M; Lovrec P; Sadowski EA; Pirasteh A
    Radiol Clin North Am; 2023 Jul; 61(4):713-723. PubMed ID: 37169433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
    Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
    Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's New in Imaging for Gynecologic Cancer?
    Khan SR; Arshad M; Wallitt K; Stewart V; Bharwani N; Barwick TD
    Curr Oncol Rep; 2017 Nov; 19(12):85. PubMed ID: 29105030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies.
    Lakhman Y; Nougaret S; Miccò M; Scelzo C; Vargas HA; Sosa RE; Sutton EJ; Chi DS; Hricak H; Sala E
    Radiographics; 2015; 35(4):1295-313. PubMed ID: 26172364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET Imaging for Gynecologic Malignancies.
    Friedman SN; Itani M; Dehdashti F
    Radiol Clin North Am; 2021 Sep; 59(5):813-833. PubMed ID: 34392921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
    Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
    J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of female pelvic tumors : Application fields of integrated PET/MRI].
    Grueneisen J; Umutlu L
    Radiologe; 2016 Jul; 56(7):605-11. PubMed ID: 27315240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/MR Imaging in Cancers of the Gastrointestinal Tract.
    Paspulati RM; Gupta A
    PET Clin; 2016 Oct; 11(4):403-23. PubMed ID: 27593246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel imaging modalities in gynecologic cancer.
    Brooks RA; Powell MA
    Curr Oncol Rep; 2009 Nov; 11(6):466-72. PubMed ID: 19840524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging in the management of gynecologic malignancies.
    Lai CH; Lin G; Yen TC; Liu FY
    Gynecol Oncol; 2014 Oct; 135(1):156-62. PubMed ID: 25065896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Computed Tomography and Magnetic Resonance Imaging in Gynecologic Oncology.
    Laifer-Narin SL; Genestine WF; Okechukwu NC; Hecht EM; Newhouse JH
    PET Clin; 2018 Apr; 13(2):127-141. PubMed ID: 29482746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG PET-CT of gynecologic cancers: pearls and pitfalls.
    Prabhakar HB; Kraeft JJ; Schorge JO; Scott JA; Lee SI
    Abdom Imaging; 2015 Oct; 40(7):2472-85. PubMed ID: 25680500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers.
    Gaeta CM; Vercher-Conejero JL; Sher AC; Kohan A; Rubbert C; Avril N
    Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):352-66. PubMed ID: 24322792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.